XML 305 R31.htm IDEA: XBRL DOCUMENT v3.24.1
Investments in associated undertakings
12 Months Ended
Dec. 31, 2023
Investments in associated undertakings  
Investments in associated undertakings

B6. Investments in associated undertakings

Retrospectively

adjusted

    

2023

    

20221

£m

£m

Interest in Nippon Calmic Limited

 

31

 

32

Interest in individually immaterial associated undertakings1

 

13

 

31

At 31 December1

 

44

 

63

1.Investments in associated undertakings have been retrospectively adjusted by an increase of £10m in 2022, in accordance with IFRS 3, to reflect measurement period adjustments made relating to the Terminix acquisition (see Note B1).

Nippon Calmic Limited

Nippon Calmic Limited is an associated undertaking in Japan which provides hygiene services, in which the Group has a 49% interest. The associate is unlisted and the investment value is shown below.

    

2023

    

2022

£m

£m

At 1 January

32

29

Exchange differences

 

(4)

 

(1)

Share of profit1

 

7

 

8

Dividends received

 

(4)

 

(4)

At 31 December

 

31

 

32

1.

Share of profit is net of tax of £4m (2022: £4m).

    

Assets 

    

Liabilities

    

Revenue

    

Profit 

    

Assets 

    

Liabilities 

    

Revenue 

    

Profit

2023

2023

2023

2023

2022

2022

2022

2022

 £m

£m

£m

 £m

£m

 £m

 £m

£m

Nippon Calmic Ltd (49%)

 

60

(28)

54

7

 

66

 

(33)

 

52

 

8

Individually immaterial associates

In addition to the interest in associates disclosed above, the Group also has interests in a number of individually immaterial associates that are accounted for using the equity method.

Retrospectively

adjusted

    

2023

    

20221

£m

£m

At 1 January

31

1

Exchange differences

 

(1)

 

(2)

Acquisitions1

 

 

31

Disposals

(19)

Share of profit

 

2

 

1

At 31 December1

 

13

 

31

1.Investments in associated undertakings have been retrospectively adjusted by an increase of £10m in 2022, in accordance with IFRS 3, to reflect measurement period adjustments made relating to the Terminix acquisition (see Note B1).

£nil (2022: £1m) relates to unrecognised share of losses related to associates.